Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
about
Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4NIEHS/FDA CLARITY-BPA research program updateA perspective on the role of estrogen in hormone-induced prostate carcinogenesisThe molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityImportance of Estrogenic Signaling and Its Mediated Receptors in Prostate CancerDevelopment of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionateOpposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostateBisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats.Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cellsTestosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male miceComparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and protein blotting.Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesisThe cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells.Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL ratsLuminal cells are favored as the cell of origin for prostate cancerDietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat modelEstrogen receptors in prostate development and cancerSerum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats.A unified mechanism in the initiation of cancer.Hormones and prostate cancer: current perspectives and future directions.Estrogen action and prostate cancer.Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.A human fetal prostate xenograft model of developmental estrogenization.Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.Hormones and prostate carcinogenesis: Androgens and estrogens.Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth.Developmental estrogen exposures predispose to prostate carcinogenesis with aging.A role for estrogen receptor beta in the regulation of growth of the ventral prostate.Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostateGene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.An evaluation of evidence for the carcinogenic activity of bisphenol A.Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromatase.Male reprotoxicity and endocrine disruption.Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
P2860
Q24648201-63E9E423-2847-48C4-9895-49EC38A5EBC0Q26800273-37548B50-58FB-4292-9FFA-4FAEC825D8F5Q27004552-6657C03A-7945-4BFF-A74F-D45736CCB9B9Q27021258-DBE061D6-3C22-433C-8D41-FEC7F8F2A5A7Q28077543-A6B5E8BE-1483-43BB-AECF-32ABBA5262A3Q28371716-32E2B9FF-C506-4FD5-8376-AD69D4E3AFBAQ28575456-51F6ADC0-9766-4650-941D-8683D42FBE2AQ30354593-A5D60CDF-F98B-4979-B107-245BE72EE3D1Q30426649-24E5E22A-B619-4C78-8597-C67EE4168B49Q30525673-BB65E9E3-63E5-4D13-A6C7-C5A889835E4EQ30686407-65864D37-142A-4622-9DE4-3E15B82941F5Q31912859-4DFDC2D7-2DE2-41DA-A158-53096E652428Q33295021-F3379FB7-3317-43D4-B381-420C968E0DB6Q33642456-DAA1D1C9-4A01-4D1E-85D1-EEAD0C24774CQ33660177-8C923D51-3760-4CC5-9603-0CC72E734068Q33708061-C3725434-8FBB-4BF6-A456-CFDA9B920766Q34025688-4EA467A2-9749-4395-8DB8-7236E32756B0Q34175508-DA9A9B0B-47FD-4A80-AF16-E1E52A4740DEQ34372606-D90831BC-FA97-4E6E-85D5-60C38F57EF10Q34448194-DB75E374-7180-402A-A031-E4FE79095288Q34553299-1F6BF4A0-5CAF-4DC3-9939-424A97385E28Q34614541-487B15DF-28C7-45A6-8E3D-FE574A0F84C3Q34732880-8A9ECD05-3C43-49EE-9636-CEF253A80B75Q35099011-1FC18BC4-DA10-44A7-9F7B-9DB2883817C7Q35116362-A11934C5-0563-4759-BF05-E7575A99E783Q35537043-2A1780BD-9671-4DE9-A07B-366EC18BAA7FQ35580183-D769539B-B841-4AE6-B2B9-CBAD6E2A1249Q35687198-7CB3DD73-04E7-4FE6-A787-83E7AAEA5CEEQ35753227-1F288663-ACFA-495E-8C3A-9E35F786C8A9Q35843249-A48CA8D7-E5E1-4706-94B7-08B35522E12EQ35903630-05648B47-902F-4E74-AF6D-E575B2BAE65CQ35941884-49744DFD-AAA2-4FC7-8B0D-65EBDD49C7C4Q35998616-0F88EA53-7465-434D-88F0-B83D5D8511A9Q36215486-2A2F67E4-C0AA-481A-B388-E855B8C86A7FQ36409841-2B03B642-B01D-4EAE-A5D0-0C710F19B247Q36598404-2A9023D3-7F5F-4A11-9569-8E60F0566FC9Q36742757-3D06B53F-C3BD-4215-ADD0-9670EE72BA1CQ36824256-B3AEB885-2ECA-4DB0-9DCA-1AB6D103C11EQ36833409-E4AC0CC1-D22F-4B0A-976A-16991BB27C30Q37139054-8C2258DD-B11D-4654-AED8-193F4C32051E
P2860
Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@en
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@nl
type
label
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@en
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@nl
prefLabel
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@en
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@nl
P2093
P356
P1433
P1476
Induction at high incidence of ...... 17 beta or diethylstilbestrol.
@en
P2093
P304
P356
10.1093/CARCIN/16.6.1311
P407
P577
1995-06-01T00:00:00Z